TIRZA 2.5 SC Injection contains Tirzepatide 2.5 mg. It is a dual GIP and GLP-1 receptor agonist medicine used to improve blood glucose control and support weight management in eligible patients.
Uses:
-
Treatment of type 2 diabetes mellitus
-
Helps improve blood sugar control along with diet and exercise
-
Supports weight management in eligible patients
-
Helps regulate appetite and glucose metabolism
Dose:
-
Adults: Usually started with 2.5 mg once weekly as an initial dose or as directed by a physician
-
Administered by subcutaneous injection (under the skin)
-
Inject on the same day each week, with or without meals
-
Dose may be increased gradually according to the patient’s response and medical advice
-
Follow the prescribed dose and duration as advised by a healthcare professional